All public logs
Jump to navigation
Jump to search
Combined display of all available logs of wikidoc. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
- 05:50, 16 April 2024 Edzelco talk contribs created page Capivasertib (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=Capivasertib |aOrAn=a |drugClass=kinase inhibitor in combination with fulvestrant |indicationType=treatment |indication=adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer with one or more PIK3CA/AKT1/PTEN-alterations as detected by an FDA-approved test following progression on at least one endocrine-based...")
- 05:27, 16 April 2024 Edzelco talk contribs created page Iptacopan (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=iptacopan |aOrAn=a |drugClass=complement factor B inhibitor |indicationType=treatment |indication=paroxysmal nocturnal hemoglobinuria |blackBoxWarningTitle=WARNING: SERIOUS INFECTIONS CAUSED BY ENCAPSULATED BACTERIA |blackBoxWarningBody=<span style="clear;"> FABHALTA increases the risk of serious and life-threatening infections caused by encapsulated bacteria, including Streptococcus pneumoniae, Neisseria me...")
- 07:24, 15 April 2024 Edzelco talk contribs created page Vutrisiran (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=vutrisiran |aOrAn=a |drugClass=transthyretin-directed small interfering RNA |indicationType=treatment |indication=polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. |adverseReactions=pain in extremity, arthralgia, dyspnea, and decreased vitamin A levels. |fdaLIADAdult=Recommended Dosage The recommended dosage of AMVUTTRA is 25 mg administered by subcutaneous inj...")
- 20:06, 11 April 2024 User account Bilal Farhat Ali talk contribs was created by Alberto Castro Molina talk contribs
- 19:20, 10 April 2024 Kosar Doraghi talk contribs created page File:IMG 1037.jpeg
- 19:20, 10 April 2024 Kosar Doraghi talk contribs uploaded File:IMG 1037.jpeg
- 23:28, 3 April 2024 Kosar Doraghi talk contribs created page File:IMG 0918.jpeg
- 23:28, 3 April 2024 Kosar Doraghi talk contribs uploaded File:IMG 0918.jpeg
- 20:13, 27 March 2024 M. Arsalan Bashir talk contribs created page User:M. Arsalan Bashir (Created page with "I’m an aspiring Neuroscientist and Neurology MD candidate, having earned my MBBS degree from Ziauddin University. My journey has led me to research, where I am wholeheartedly committed to enhancing treatment methods and increasing knowledge to challenge the stigma often linked with neurological conditions.") Tag: Visual edit
- 11:08, 27 March 2024 Imam Ali Shah talk contribs created page File:Bismuth Subnitrate Package and Label Display Panel.jpg
- 11:08, 27 March 2024 Imam Ali Shah talk contribs uploaded File:Bismuth Subnitrate Package and Label Display Panel.jpg
- 09:51, 27 March 2024 Imam Ali Shah talk contribs created page Bismuth subnitrate (Created page with "dasda") Tag: Visual edit
- 09:13, 26 March 2024 Imam Ali Shah talk contribs created page User:Imam Ali Shah (Created page with "=='''Imam Ali Shah, MBBS'''== Contact:Email: imamshah.med@gmail.com ==Medical Education== *'''2017-2022''' **MBBS Chandka Medical College, Pakistan ==Professional Affiliations== *Profesional Aff...")
- 08:33, 21 March 2024 Alara E. Dagsali talk contribs created page Norelgestromin (Created page with "{{DrugProjectFormSinglePage |authorTag=Alara E.Dagsali |OTC=Yes |genericName=NORELGESTROMIN AND ETHINLY ESTRADIOL patch |indicationType=prevention |indication=Norelgestromin and ethinyl estradiol transdermal system is indicated for the prevention of pregnancy in women with a body mass index (BMI) < 30 kg/m for whom a combined hormonal contraceptive is appropriate. |hasBlackBoxWarning=Yes |adverseReactions=The following serious adverse reactions with the use of co...")
- 05:58, 21 March 2024 Kosar Doraghi talk contribs created page File:IMG 0885.jpeg
- 05:58, 21 March 2024 Kosar Doraghi talk contribs uploaded File:IMG 0885.jpeg
- 23:07, 19 March 2024 Kosar Doraghi talk contribs created page Ryzneuta (Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D.[mailto:k.doraghi@yahoo.com]] |genericName=RYZNEUTA -Efbemalenograstim alfa-vuxw |aOrAn=a |drugClass=leukocyte growth factor |indicationType=treatment |indication=and decrease the incidence of infection, as manifested by [febrile neutropenia], in adult patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia |h...")
- 10:01, 12 March 2024 Hafiza Amna Qadeer talk contribs created page Rezafungin (Created page with "{{DrugProjectFormSinglePage |authorTag=HAFIZA AMNA QADEER |OTC=Yes |genericName=REZAFUNGIN |aOrAn=an |drugClass=echinocandin antifungal |indicationType=treatment }}")
- 17:24, 5 March 2024 User account Imam Ali Shah talk contribs was created by Alberto Castro Molina talk contribs
- 17:17, 5 March 2024 User account M. Arsalan Bashir talk contribs was created by Alberto Castro Molina talk contribs
- 18:02, 3 March 2024 Marshallsumter talk contribs created page Non-degenerate nucleotides per response element (Created page with " {| class="wikitable sortable" |+ Number of non-degenerate nucleotides versus number of response elements |- ! Number of nucleotides !! Letters of nucleotides !! Number of response elements !! Average ± deviation !! Order of list |- | 1 || A || 295 || 295.0 ± 0.0 || 1 |- | 1 || T || 285 || - || 1 |- | 1 || G || 286 || - || 3 |- | 1(4) || C || 300 || 291.5 ± 6 || 5 |- | 2 || AA || 105 || 105 ± 0.0 || 1 |- | 2 || AT || 105 || 105 ± 0.0 || 1 |- | 2 || TA || 74 |...")
- 02:16, 29 February 2024 Alen Antony talk contribs created page Lecanemab-irmb (Created page with "{{DrugProjectFormSinglePage |authorTag={{AAP}} |genericName=lecanemab-irmb |aOrAn=a |drugClass=recombinant humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody |indicationType=treatment |indication=Alzheimer’s disease. This drug is ideally initiated during the early phase of dementia or mild cognitive impairment (which was the population tested in the clinical trials of this drug). |hasBlackBoxWarning=Yes |adverseReactions=Amyloid Related Imaging Abnorma...")
- 02:40, 28 February 2024 Kosar Doraghi talk contribs created page Vonoprazan fumarate (Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D.[mailto:k.doraghi@yahoo.com] |genericName=vonoprazan fumarate |aOrAn=a |drugClass=potassium-competitive acid blocker |indicationType=treatment |indication=all grades of erosive esophagitis and relief of heartburn associated with erosive esophagitis in adults. *to maintain healing of all grades of erosive esophagitis and relief of heartburn associated with erosive esophagitis in adults. *in combinatio...")
- 21:36, 23 February 2024 Kosar Doraghi talk contribs created page Nedosiran (Created page with "{{DrugProjectFormSinglePage |authorTag={{KDRG}} |genericName=nedosiran |aOrAn=an |drugClass=LDHA-directed small interfering RNA |indicationType=treatment |indication=lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, e.g., eGFR ≥ 30 mL/min/1.73 m2 |adverseReactions=injection site reactions |fdaLIADAdult=RIVFLOZA Injection 160 mg/mL is a clear, colorless-t...")
- 21:25, 23 February 2024 Kosar Doraghi talk contribs created page File:IMG 0866.jpeg
- 21:25, 23 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0866.jpeg
- 21:24, 23 February 2024 Kosar Doraghi talk contribs created page File:IMG 0864.jpeg
- 21:24, 23 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0864.jpeg
- 21:21, 23 February 2024 Kosar Doraghi talk contribs created page File:IMG 0858.jpeg
- 21:21, 23 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0858.jpeg
- 21:20, 23 February 2024 Kosar Doraghi talk contribs created page File:IMG 0861.jpeg
- 21:20, 23 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0861.jpeg
- 21:20, 23 February 2024 Kosar Doraghi talk contribs created page File:IMG 0860.jpeg
- 21:20, 23 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0860.jpeg
- 21:19, 23 February 2024 Kosar Doraghi talk contribs created page File:IMG 0859.jpeg
- 21:19, 23 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0859.jpeg
- 21:17, 23 February 2024 Kosar Doraghi talk contribs created page File:IMG 0867.jpeg
- 21:17, 23 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0867.jpeg
- 21:11, 23 February 2024 Kosar Doraghi talk contribs created page File:IMG 0857.jpeg
- 21:11, 23 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0857.jpeg
- 21:09, 23 February 2024 Kosar Doraghi talk contribs created page File:IMG 0856.jpeg
- 21:09, 23 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0856.jpeg
- 21:06, 23 February 2024 Kosar Doraghi talk contribs created page File:IMG 0855.jpeg
- 21:06, 23 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0855.jpeg
- 21:05, 23 February 2024 Kosar Doraghi talk contribs created page File:IMG 0853.jpeg
- 21:05, 23 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0853.jpeg
- 20:53, 23 February 2024 Kosar Doraghi talk contribs created page File:IMG 0852.jpeg
- 20:53, 23 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0852.jpeg
- 04:16, 23 February 2024 Kosar Doraghi talk contribs created page Nirogacestat (Created page with "{{DrugProjectFormSinglePage |authorTag={{KDRG}} |genericName=nirogacestat |aOrAn=a |drugClass=gamma secretase inhibitor |indicationType=treatment |indication=adult patients with progressing desmoid tumors who require systemic treatment |hasBlackBoxWarning=Yes |adverseReactions=diarrhea, ovarian toxicity, rash, nausea, fatigue, stomatitis, headache, abdominal pain, cough, alopecia, upper respiratory tract infection and [...")
- 04:05, 23 February 2024 Kosar Doraghi talk contribs created page File:IMG 0851.jpeg
- 04:05, 23 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0851.jpeg
- 04:00, 23 February 2024 Kosar Doraghi talk contribs created page File:IMG 0848.jpeg
- 04:00, 23 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0848.jpeg
- 03:59, 23 February 2024 Kosar Doraghi talk contribs created page File:IMG 0850.jpeg
- 03:59, 23 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0850.jpeg
- 03:57, 23 February 2024 Kosar Doraghi talk contribs created page File:IMG 0847.jpeg
- 03:57, 23 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0847.jpeg
- 16:45, 22 February 2024 Mohammad Nikoohemmat talk contribs created page Sandbox:MNH (Created page with "=====bold kardan subtitle=====")
- 13:31, 22 February 2024 Mohammad Nikoohemmat talk contribs created page Birch triterpenes (Created page with "{{DrugProjectFormSinglePage |authorTag=Mohammad Nikoohemmat |genericName=birch triterpenes }}")
- 13:24, 22 February 2024 Mohammad Nikoohemmat talk contribs created page Eplontersen (Created page with "{{DrugProjectFormSinglePage |authorTag=Mohammad Nikoohemmat |genericName=Eplontersen |aOrAn=a |drugClass=transthyretin-directed antisense oligonucleotide |indicationType=treatment |indication=WAINUA is indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. |adverseReactions=Most common adverse reactions (that occurred in at least 9% of patients treated with WAINUA) were vitamin A decreased and vomiting. |fdaLIADAdult...")
- 12:33, 22 February 2024 Mohammad Nikoohemmat talk contribs created page Template:MNH (Created page with "Mohammad Nikoohemmat, M.D.[mailto:mohammadnikoo1375@gmail.com]")
- 16:38, 21 February 2024 Badgettrg talk contribs created page Template:Math2 (Created page with "<span class="texhtml {{#if:{{{big|}}}{{{size|}}}|texhtml-big}}" {{#if:{{{big|}}}{{{size|}}}|style="font-size:{{{size|165%}}};"}}>{{{1}}}</span><!-- -->{{#invoke:Check for unknown parameters|check | unknown = {{main other|_VALUE_}} | showblankpositional=1 | preview = unknown parameter "_VALUE_" (consider using <code>{{!}}1=</code>, <code><nowiki>{{!}}</nowiki></code>, <code><nowiki>{{=}}</nowiki></code>) | 1 | big | si...")
- 06:21, 21 February 2024 Alen Antony talk contribs created page Olutasidenib (Created page with "{{DrugProjectFormSinglePage |authorTag={{AAP}} |genericName=Olutasidenib |aOrAn=a |drugClass=isocitrate dehydrogenase-1 (IDH1) inhibitor |indicationType=treatment |indication=relapsed or refractory acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation. |hasBlackBoxWarning=Yes |adverseReactions=nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite, mucositis, arthralgia, fatigue, pyrexia...")
- 14:13, 20 February 2024 Badgettrg talk contribs created page Treatment outcome (Created page with "{{SI}} {{RGB}} In Quality of Health Care, '''{{PAGENAME}}''' is defined as "Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series."<ref>{{MeSH}}</ref> ==Statistical methods== * The minimal clinically important differences (MCID) has been proposed as >0.5 standard deviation imp...")
- 15:11, 19 February 2024 Matt Pijoan talk contribs created page Template:Image (Created page with "<templatestyles src="Image/styles.css"/><div class="t-image {{#ifeq:{{{padding|}}}|no||t-image-padding}}" {{#if:{{{width|}}}|style="max-width:{{{width}}}%"}}> [[File:{{{file|File:MattP(1).png}}}|{{{imagewidth|400}}}px|{{#ifeq:{{{border|}}}|yes|border{{!}}}}alt={{{caption|}}}|{{#if:{{{link|}}}|link={{{link|}}}}}]]{{#if: {{{caption|}}}| <p class="t-image-caption"> {{{caption}}} </p>}} </div><noinclude> {{documentation|content= {{Uses TemplateStyles|Template:Image/styles.cs...")
- 16:17, 18 February 2024 Badgettrg talk contribs created page Back pain monitoring response to therapy (Created page with "__NOTOC__ {{Back pain}} {{CMG}} {{AE}} {{ZMalik}} ==Overview== The Oswestry low back pain disability questionnaire (ODQ) can measure the response to therapy.<ref name="pmid6450426">{{cite journal| author=Fairbank JC, Couper J, Davies JB, O'Brien JP| title=The Oswestry low back pain disability questionnaire. | journal=Physiotherapy | year= 1980 | volume= 66 | issue= 8 | pages= 271-3 | pmid=6450426 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi...")
- 03:15, 16 February 2024 Kosar Doraghi talk contribs created page Lasmiditan (Created page with "{{DrugProjectFormSinglePage |authorTag={{KDRG}} |genericName=Lasmiditan (REYVOW) |aOrAn=a |drugClass=serotonin (5-HT) 1F receptor agonist |indicationType=treatment |indication=migraine with or without aura in adults |hasBlackBoxWarning=Yes |adverseReactions=dizziness, fatigue, paresthesia, and sedation |blackBoxWarningTitle=Warning |blackBoxWarningBody=Driving Impairment: *Central Nervous System (CNS) Depression: Do not use in combination...")
- 03:03, 16 February 2024 Kosar Doraghi talk contribs created page File:IMG 0837.jpeg
- 03:03, 16 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0837.jpeg
- 02:58, 16 February 2024 Kosar Doraghi talk contribs created page File:IMG 0839.jpeg
- 02:58, 16 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0839.jpeg
- 02:56, 16 February 2024 Kosar Doraghi talk contribs created page File:IMG 0838.jpeg
- 02:56, 16 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0838.jpeg
- 06:30, 15 February 2024 Alen Antony talk contribs created page Lenacapavir (Created page with "{{DrugProjectFormSinglePage |authorTag={{AAP}} |genericName=lenacapavir }}")
- 02:00, 15 February 2024 Alara E. Dagsali talk contribs created page 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC) (Created page with "{{ADA guidelines}} {{CMG}} {{AE}} {{SCh}}; {{MehdiP}}; {{TarekNafee}} ==2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC)<ref name="pmid37622663">{{cite journal| author=Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ | display-authors=etal| title=2023 ESC Guidelines f...")
- 01:01, 15 February 2024 Kosar Doraghi talk contribs created page Ponesimod (Created page with "{{DrugProjectFormSinglePage |authorTag={{KDRG}} |genericName=Ponesimod (PONVORY) |aOrAn=a |drugClass=sphingosine 1-phosphate receptor modulator |indicationType=treatment |indication=relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults |hasBlackBoxWarning=Yes |adverseReactions=upper respiratory tract infection, hepatic transaminase elevation, and ...")
- 00:56, 15 February 2024 Kosar Doraghi talk contribs created page File:IMG 0834.jpeg
- 00:56, 15 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0834.jpeg
- 00:55, 15 February 2024 Kosar Doraghi talk contribs created page File:IMG 0833.jpeg
- 00:55, 15 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0833.jpeg
- 00:49, 15 February 2024 Kosar Doraghi talk contribs created page File:IMG 0832.jpeg
- 00:49, 15 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0832.jpeg
- 00:48, 15 February 2024 Kosar Doraghi talk contribs created page File:IMG 0829.jpeg
- 00:48, 15 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0829.jpeg
- 00:46, 15 February 2024 Kosar Doraghi talk contribs created page File:IMG 0831.jpeg
- 00:46, 15 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0831.jpeg
- 21:25, 14 February 2024 Alen Antony talk contribs created page Tirzepatide (Created page with "{{DrugProjectFormSinglePage |authorTag={{AAP}} |genericName=tirzepatide |aOrAn=a |drugClass=glucagon-like peptide-1 (GLP-1) receptor agonist |indicationType=treatment |indication=type 2 diabetes mellitus in adults in adjunct to diet and exercise. |hasBlackBoxWarning=Yes |adverseReactions=pancreatitis,hypoglycemia with concomitant use of insulin or insulin secretagogues, acute kidney injury, severe gastrointestinal disease, acute gallbladder disease, dia...")
- 18:30, 14 February 2024 Kosar Doraghi talk contribs created page Dasiglucagon (Created page with "{{DrugProjectFormSinglePage |authorTag={{KDRG}} |genericName=Dasiglucagon (ZEGALOGUE) |aOrAn=an |drugClass=anti-hypoglycemic |indicationType=treatment |indication=severe hypoglycemia in pediatric and adult patients with diabetes aged 6 years and older |hasBlackBoxWarning=Yes |adverseReactions=nausea, vomiting, headache, diarrhea, and injection site pain |blackBoxWarningTitle=Allergic reactions |blackBoxWarningBody=increase in blood pressure in Patients wi...")
- 18:17, 14 February 2024 Kosar Doraghi talk contribs created page File:IMG 0828.jpeg
- 18:17, 14 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0828.jpeg
- 18:16, 14 February 2024 Kosar Doraghi talk contribs created page File:IMG 0827.jpeg
- 18:16, 14 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0827.jpeg
- 18:13, 14 February 2024 Kosar Doraghi talk contribs created page File:IMG 0822.jpeg
- 18:13, 14 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0822.jpeg
- 18:12, 14 February 2024 Kosar Doraghi talk contribs created page File:IMG 0826.jpeg
- 18:12, 14 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0826.jpeg
- 18:07, 14 February 2024 Kosar Doraghi talk contribs created page File:IMG 0824.jpeg
- 18:07, 14 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0824.jpeg
- 18:05, 14 February 2024 Kosar Doraghi talk contribs created page File:IMG 0823.jpeg
- 18:05, 14 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0823.jpeg